This 30mg research blend delivers three complementary peptides in a single vial: BPC-157, TB-500, and Cartalax. Each component contributes distinct mechanisms for laboratory research. BPC-157 (10mg) targets gastric-derived pathways. TB-500 (10mg) provides the 43-amino acid thymosin beta-4 sequence. Cartalax (10mg) offers the bioregulatory AED tripeptide.

Manufactured in USA facilities under pharmaceutical-grade standards with third-party testing verification. Supplied as sterile lyophilized powder at ≥99% purity. Designed for researchers studying connective tissue mechanisms, cellular repair pathways, and fibroblast activity in controlled laboratory settings. For in vitro research applications only.

Product Specifications

Product Usage:

This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug.

KPV (Lys–Pro–Val) is the C-terminal tripeptide fragment of α-melanocyte stimulating hormone (α-MSH). As a small, bioactive peptide, KPV reproduces many of α-MSH’s anti-inflammatory, antimicrobial and tissue-protective activities while avoiding full-length melanocortin receptor signaling in some contexts.

In research settings, KPV has been studied for:

• Potent anti-inflammatory action — suppresses pro-inflammatory cytokines and leukocyte activation
  
• Antimicrobial activity — direct candidacidal and bactericidal effects reported for α-MSH C-terminal fragments including KPV
  
• Mucosal and epithelial protection / wound healing — accelerates epithelial repair in corneal and other epithelial models
  
• Anti-fibrotic and immunomodulatory effects — reduces fibrosis and shifts macrophage phenotypes in preclinical studies
  

The KPV peptide sequence is a useful research tool for studying innate immune regulation, mucosal defense and novel anti-inflammatory peptide mechanisms.

Product Specifications

Lyophilized Peptides:

These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage. We do not use any fillers in this process.

This synthetic peptide blend combines four regenerative peptides into a single vial for studies examining complementary tissue regeneration and inflammation reduction pathways:

• GHK-Cu up-regulates wound healing processes and drives collagen production, elastin, and angiogenic growth-factor expression in laboratory models.
• BPC-157 (Body Protection Compound-157) exhibits gastro-protective, soft-tissue repair, and anti-inflammatory actions through nitric-oxide signaling, growth-factor receptor modulation, and cytokine balance.
• TB-500 (Thymosin Beta-4 Fragment) enhances cell migration and angiogenesis via actin-sequestering and integrin-linked pathways.
• KPV (Lys-Pro-Val) functions as an anti-inflammatory tripeptide that modulates immune signaling cascades, inhibits inflammatory cytokine production, and regulates mast cell activation without melanocortin receptor binding.

Researchers can examine potential synergy across copper-mediated extracellular-matrix activation (GHK-Cu), cytoprotective signaling (BPC-157), actin-dependent cell motility (TB-500), and immune-modulatory pathways (KPV). In vitro and ex vivo models evaluate collagen deposition rates, angiogenic indices, inflammatory marker expression, and controlled tissue recovery metrics.

Composition: 80 mg lyophilized blend per vial
50 mg GHK-Cu | 10 mg BPC-157 | 10 mg TB-500 | 10 mg KPV

Peptide Information

Lyophilized Peptides

All four peptides are supplied in a freeze-dried, filler-free state to maximize stability and preserve chemical integrity during refrigerated or frozen storage. Reconstitute with sterile solvent immediately prior to experimental use and store aliquots at ≤ –20 °C to prevent repeated freeze–thaw cycles.

The BioLongevity Labs NAD+/MOTS-c/5-Amino-1MQ Blend unites three distinct compounds that converge on cellular energy, mitochondrial function, and metabolic regulation:

• NAD+ (100 mg) replenishes the central redox cofactor required for metabolism, DNA repair, and sirtuin activation [1][2][3].
  
• MOTS-c (10 mg) is a mitochondria-derived peptide that activates AMPK, regulates nuclear gene expression under metabolic stress, and enhances insulin sensitivity [4][5][6].
  
• 5-Amino-1MQ (10 mg) inhibits NNMT, raising NAD+ levels while modulating histone methylation and fat metabolism pathways [7][8][9].

Together, their mechanisms are designed to:

• Enhance mitochondrial and cellular energy balance by restoring NAD+ pools and activating AMPK [1][4][7].
  
• Improve metabolic health by reducing adiposity, sustaining muscle function, and optimizing glucose regulation [2][5][8].
  
• Support cognitive and longevity research through effects on neuroinflammation, oxidative stress, and cellular senescence [3][6][9].
  

Peptide Structures

NAD+ (Nicotinamide Adenine Dinucleotide)

• Molecular Formula: C₂₁H₂₇N₇O₁₄P₂
• Molecular Weight: 663.43 g/mol
• PubChem CID: 925
• CAS Number: 53-84-9
• Synonyms: β-Nicotinamide adenine dinucleotide, DPN, Coenzyme I, Diphosphopyridine nucleotide

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c)

• Sequence: Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg
• Molecular Formula: C₁₀₁H₁₅₂N₂₈O₂₂S₂
• Molecular Weight: 2174.6 g/mol
• PubChem SID: 255386757
• CAS Number: 1627580-64-6
• Synonyms: Human MOTS-c, UNII-A5CV6JFB78, MOTS-c trifluoroacetate salt

5-Amino-1MQ (5-Amino-1-methylquinolinium)

• Molecular Formula: C₁₀H₁₁N₂
• Molecular Weight: 159.21 g/mol
• PubChem CID: 950107
• CAS Number: —
• Synonyms: 5-amino-1-methylquinolinium, SCHEMBL6403148, CHEMBL4116828, ZMJBCEIHNOWCMC-UHFFFAOYSA-O, STL196667

This synergistic triad provides a unique investigational platform for metabolism, neuroprotection, and healthy aging research.

Blend Structure

Research Areas

• Cellular Energy & Mitochondrial Function
  
• Metabolic Regulation & Obesity Research
  
• Muscle Preservation & Physical Performance
  
• Neuroprotection & Cognitive Function
  
• Longevity & Anti-Aging Mechanisms
  
• Preclinical Cancer Research

PNC-27 is a synthetic peptide designed to selectively kill cancer cells by targeting a protein called HDM-2 (also known as MDM2) found on the membranes of many cancer cells. It works by binding to membrane-bound HDM-2, forming pores in the cancer cell membrane, and causing rapid cell death through necrosis, while sparing normal cells.

PNC-27 is derived from the p53 protein’s HDM-2 binding domain (amino acids 12-26) and is linked to a membrane-penetrating sequence, allowing it to enter and act on cancer cell membranes. The peptide binds specifically to HDM-2 present on the surface of cancer cells, not normal cells. This binding leads to the formation of transmembrane pores, disrupting the cell membrane and causing cell lysis and necrosis, independent of the p53 pathway.

Peptide Information

PNC-27 Peptide Structure

Source: PubChem

Lyophilized Peptides:

These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage. We do not use any fillers in this process.

5-Amino-1MQ is a synthetic small molecule that inhibits the enzyme nicotinamide N-methyltransferase (NNMT). By blocking NNMT, it shifts intracellular NAD+ and S-adenosylmethionine (SAM) levels, two cofactors tied to energy metabolism, redox balance, and gene regulation in laboratory models.

In cultured cells and rodent models, researchers have used 5-Amino-1MQ to study lipid metabolism, adipose tissue biology, and cellular aging pathways. This methylquinolinium derivative is a research compound of interest for fundamental studies of metabolic regulation.

BioLongevity Labs supplies 5-Amino-1MQ for research use only.

Compound Information

5-Amino-1MQ Peptide Structure

Source: PubChem

Lyophilized Format

This compound ships in lyophilized (freeze-dried) form. Freeze-drying supports long-term storage stability and preserves compound integrity. No fillers are added.

Product Usage

This product is intended as a research chemical only. This designation allows use strictly for in vitro testing and laboratory experimentation. All product information on this website is for educational purposes only. This product should be handled only by licensed, qualified professionals. It is not a drug, food, or cosmetic and may not be misbranded, misused, or mislabeled.

Research Applications

PEG MGF (Pegylated Mechano Growth Factor) is a synthetic, modified form of MGF, which is a split variant of Insulin-like Growth Factor-1 (IGF-1). Through a process called pegylation, a polyethylene glycol (PEG) molecule is attached to the MGF peptide, significantly enhancing its stability for research use.

This peptide preferentially targets recently stressed or damaged muscle cell tissue, making it particularly suited for laboratory studies investigating muscle growth, repair and recovery.

Peptide Information

Lyophilized Peptides:

These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage. We do not use any fillers in this process.

GLOW pairs three peptides that are each studied in separate lines of regenerative research. GHK-Cu is a copper-binding tripeptide investigated in connective-tissue and matrix-remodeling models. BPC-157 is a 15-residue peptide studied in angiogenesis and cell-migration research. TB-500 corresponds to the actin-binding region of thymosin beta-4 and is examined in cytoskeletal-dynamics models.

Combining the three in one vial lets researchers study how copper-mediated matrix activity, cytoprotective signaling, and actin-dependent motility behave alongside one another under controlled in vitro conditions.

Each vial holds 70 mg of lyophilized blend: 50 mg GHK-Cu, 10 mg BPC-157, and 10 mg TB-500.

Compound Information

Blend composition: 70 mg total per vial (50 mg GHK-Cu, 10 mg BPC-157, 10 mg TB-500). Storage: -20°C, protect from light.

Storage and Handling

• Store the lyophilized blend at -20°C, protected from light.
• After reconstitution with sterile solvent, store refrigerated and use promptly.
• Aliquot to avoid repeated freeze-thaw cycles.
• Maintain aseptic handling to preserve compound integrity.

Lyophilized Format

This blend ships in lyophilized (freeze-dried) form. Freeze-drying supports long-term storage stability and preserves compound integrity. No fillers are added.

Research Use Disclaimer

GLOW peptide blend is supplied for research use only. It is not a drug, food, cosmetic, or dietary supplement, has not been evaluated by the FDA. By purchasing, the buyer confirms the compound will be used solely for in vitro research.

Cagrilintide is a novel long-acting amylin analog featuring N-terminal lipidation that extends its half-life by binding to albumin. This synthetic peptide mimics and enhances natural amylin’s effects, simultaneously targeting multiple metabolic and appetite regulation pathways in both homeostatic and hedonic systems.

Peptide Information

Cagrilintide Peptide Structure

Source: PubChem

Lyophilized Peptides:

Our cagrilintide is provided as a lyophilized (freeze-dried) powder. This process extends shelf life and preserves the purity and integrity of the peptide without the use of any fillers.